Perspective Therapeutics, Inc. (CATX) investor relations documents from the company's IR site: 4 presentations, 7 press releases; latest deck 2026-07-01. Read in-app with summaries. First-party data.
https://assets.thevendorgroup.com/site/414442af-80d0-4ecb-95fd-86a6af34913f/2026/07/01/6a45439d933b74db97c44351/CATX Cor: Perspective Therapeutics (CATX) is developing 212Pb-based targeted alpha therapies for oncology, reporting a 43% ORR for its lead candidate, VMT-α-NET.
| Published | Type | Document |
|---|---|---|
| 2026-08-10 | Press release | Perspective Therapeutics Provides Recent Business Highlights and Reports 2Q 2026 Results |
| 2026-07-31 | Press release | Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2026 Financial Results |
| 2026-07-28 | Press release | July 28, 2026 READ MORE |
| 2026-07-08 | Press release | July 8, 2026 READ MORE |
| 2026-07-01 | Presentation | https://assets.thevendorgroup.com/site/414442af-80d0-4ecb-95fd-86a6af34913f/2026/07/01/6a45439d933b74db97c44351/CATX Cor |
| 2026-06-03 | Press release | June 3, 2026 READ MORE |
| 2026-05-18 | Press release | May 18, 2026 READ MORE |
| Press release | Perspective Therapeutics Provides Recent Business Highlights and Reports 1Q 2026 Results | |
| 2026-05-04 | Presentation | Slide Presentation |
| Presentation | https://assets.thevendorgroup.com/site/414442af-80d0-4ecb-95fd-86a6af34913f/2026/05/31/6a1c9e9f8cdab2a95e838f5e/CATX Corporate Deck 2026-06-01.pdf | |
| Presentation | VMT-a-NET Interim Data |
CATX overview · CATX earnings · CATX financials · CATX KPIs · CATX ownership · CATX peers · CATX filings
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.